Standardized, systemic phenotypic analysis of Slc12a1 I299F mutant mice
Authors:
- Elisabeth KemterElisabeth Kemter
- Birgit RathkolbBirgit Rathkolb
- Lore BeckerLore Becker
- Ines BolleInes Bolle
- Dirk H BuschDirk H Busch
- Claudia DalkeClaudia Dalke
- Ralf ElvertRalf Elvert
- Jack FavorJack Favor
- Jochen GrawJochen Graw
- Wolfgang HansWolfgang Hans
- Boris IvandicBoris Ivandic
- Svetoslav KalaydjievSvetoslav Kalaydjiev
Open Access
- 2 August 2014
- journal article
- research article
- Published by Springer Nature in Journal of Biomedical Science
- Vol. 21 (1) , 68
Abstract
Type I Bartter syndrome is a recessive human nephropathy caused by loss-of-function mutations in the SLC12A1 gene coding for the Na+-K+-2Cl− cotransporter NKCC2. We recently established the mutant mouse line Slc12a1 I299F exhibiting kidney defects highly similar to the late-onset manifestation of this hereditary human disease. Besides the kidney defects, low blood pressure and osteopenia were revealed in the homozygous mutant mice which were also described in humans. Beside its strong expression in the kidney, NKCC2 has been also shown to be expressed in other tissues in rodents i.e. the gastrointestinal tract, pancreatic beta cells, and specific compartments of the ear, nasal tissue and eye. To examine if, besides kidney defects, further organ systems and/or metabolic pathways are affected by the Slc12a1 I299F mutation as primary or secondary effects, we describe a standardized, systemic phenotypic analysis of the mutant mouse line Slc12a1 I299F in the German Mouse Clinic. Slc12a1 I299F homozygous mutant mice and Slc12a1 I299F heterozygous mutant littermates as controls were tested at the age of 4–6 months. Beside the already published changes in blood pressure and bone metabolism, a significantly lower body weight and fat content were found as new phenotypes for Slc12a1 I299F homozygous mutant mice. Small additional effects included a mild erythropenic anemia in homozygous mutant males as well as a slight hyperalgesia in homozygous mutant females. For other functions, such as immunology, lung function and neurology, no distinct alterations were observed. In this systemic analysis no clear primary effects of the Slc12a1 I299F mutation appeared for the organs other than the kidneys where Slc12a1 expression has been described. On the other hand, long-term effects additional and/or secondary to the kidney lesions might also appear in humans harboring SLC12A1 mutations.Keywords
This publication has 29 references indexed in Scilit:
- Innovations in phenotyping of mouse models in the German Mouse ClinicMammalian Genome, 2012
- Expression of the Na+-K+-2Cl--Cotransporter 2 in the Normal and Pressure-Induced Ischemic Rat RetinaKorean Journal of Ophthalmology, 2012
- Molecular regulation of NKCC2 in the thick ascending limbAmerican Journal of Physiology-Renal Physiology, 2011
- Rare mutations in the human Na-K-Cl cotransporter (NKCC2) associated with lower blood pressure exhibit impaired processing and transport functionAmerican Journal of Physiology-Renal Physiology, 2011
- Rare mutations in SLC12A1 and SLC12A3 protect against hypertension by reducing the activity of renal salt cotransportersJournal Of Hypertension, 2011
- Differential regulation of the bumetanide-sensitive cotransporter (NKCC2) by ovarian hormonesSteroids, 2010
- Isoforms of renal Na-K-2Cl cotransporter NKCC2: expression and functional significanceAmerican Journal of Physiology-Renal Physiology, 2008
- Expression of the Na+–K+–2Cl− cotransporter in the rat endolymphatic sacBiochemical and Biophysical Research Communications, 2007
- Mechanisms of neuronal chloride accumulation in intact mouse olfactory epitheliumThe Journal of Physiology, 2007
- Macula Densa Control of Renin Secretion and Preglomerular Resistance in Mice with Selective Deletion of the B Isoform of the Na,K,2Cl Co-TransporterJournal of the American Society of Nephrology, 2006